These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22942128)

  • 1. Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary intervention.
    Zhang JW; Zhou YJ; Yang Q; Yang SW; Nie B; Xu XH
    Angiology; 2013 Aug; 64(6):430-4. PubMed ID: 22942128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Zhang JW; Zhou YJ; Cao SJ; Yang Q; Yang SW; Nie B
    Coron Artery Dis; 2013 Aug; 24(5):352-6. PubMed ID: 23835666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.
    Zhang XL; Chi YH; Wang le F; Wang HS; Lin XM
    Respirology; 2014 Jul; 19(5):723-9. PubMed ID: 24750361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of chronic obstructive pulmonary disease in ST-elevation myocardial infarction after primary angioplasty.
    Lazzeri C; Valente S; Attanà P; Chiostri M; Picariello C; Gensini GF
    Eur J Prev Cardiol; 2013 Jun; 20(3):392-8. PubMed ID: 22023803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study.
    Almagro P; Lapuente A; Pareja J; Yun S; Garcia ME; Padilla F; Heredia JL; De la Sierra A; Soriano JB
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1353-61. PubMed ID: 26213464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention.
    Selvaraj CL; Gurm HS; Gupta R; Ellis SG; Bhatt DL
    Am J Cardiol; 2005 Sep; 96(6):756-9. PubMed ID: 16169353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
    Ke D; Zhong W; Fan L; Chen L
    Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of chronic obstructive pulmonary disease on patient with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Sung PH; Chung SY; Sun CK; Yang CH; Chen SM; Hang CL; Chen CJ; Yeh KH; Chen YL; Wu CJ; Chang HW; Tsai TH; Yip HK
    Biomed J; 2013; 36(6):274-81. PubMed ID: 24385069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction.
    Wakabayashi K; Gonzalez MA; Delhaye C; Ben-Dor I; Maluenda G; Collins SD; Syed AI; Gaglia MA; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2010 Aug; 106(3):305-9. PubMed ID: 20643237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Phenotype of Chronic Obstructive Pulmonary Disease With Frequent Exacerbations in the Aspect of Long-term Percutaneous Coronary Intervention Results].
    Zafiraki VK; Namitokov AM; Skaletsky KV; Kosmacheva ED; Shulzhenko LV; Ramazanov JM; Omarov AA; Pershukov IV
    Kardiologiia; 2017 Mar; 57(3):51-57. PubMed ID: 28762936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild-to-moderate COPD as a risk factor for increased 30-day mortality in cardiac surgery.
    Ried M; Unger P; Puehler T; Haneya A; Schmid C; Diez C
    Thorac Cardiovasc Surg; 2010 Oct; 58(7):387-91. PubMed ID: 20922620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.
    Saleh HZ; Mohan K; Shaw M; Al-Rawi O; Elsayed H; Walshaw M; Chalmers JA; Fabri BM
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):108-13; discussion 113. PubMed ID: 22290913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midterm follow-up of patients with perioperative myocardial infarction after coronary artery bypass surgery: clinical significance of different treatment strategies.
    Alexiou K; Wilbring M; Koch C; Kappert U; Tugtekin S; Matschke K
    Thorac Cardiovasc Surg; 2012 Oct; 60(7):452-61. PubMed ID: 22547303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dilemma of success: percutaneous coronary interventions in patients > or = 75 years of age-successful but associated with higher vascular complications and cardiac mortality.
    Assali AR; Moustapha A; Sdringola S; Salloum J; Awadalla H; Saikia S; Ghani M; Hale S; Schroth G; Rosales O; Anderson HV; Smalling RW
    Catheter Cardiovasc Interv; 2003 Jun; 59(2):195-9. PubMed ID: 12772238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI.
    Leone AM; Sgueglia GA; Porto I; Niccoli G; Burzotta F; Trani C; De Caterina AR; Buffon A; Mazzari MA; Mongiardo R; Rebuzzi AG; Crea F
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):775-82. PubMed ID: 22048665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between COPD and outcomes after percutaneous coronary intervention.
    Konecny T; Somers K; Orban M; Koshino Y; Lennon RJ; Scanlon PD; Rihal CS
    Chest; 2010 Sep; 138(3):621-7. PubMed ID: 20382719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major adverse cardiac events and mortality in chronic obstructive pulmonary disease following percutaneous coronary intervention: a systematic review and meta-analysis.
    Bundhun PK; Gupta C; Xu GM
    BMC Cardiovasc Disord; 2017 Jul; 17(1):191. PubMed ID: 28716059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the predictive value of EuroSCORE, SYNTAX score, and clinical SYNTAX score for outcomes of patients undergoing percutaneous coronary intervention for unprotected left main coronary artery disease.
    Jou YL; Lu TM; Chen YH; Sung SH; Wang KL; Huang SS; Lin WT; Chan WL; Lin SJ
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):222-30. PubMed ID: 22334399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.
    Laynez A; Sardi G; Hauville C; Barbash IM; Pakala R; Torguson R; Xue Z; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):759-65. PubMed ID: 22488756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.